The first Altimmune trade was made in Q3 2018.
Since then Jim Simons bought shares eleven more times and sold shares on seven occasions. The investor completely sold their stake between Q3 2023 and Q4 2023.
Avg closing price
Price range
Sold -331 Thousand shares
Q4 2023
Avg closing price
$4.18
Price range
$2.14
-
$11.62
Sold 49.8% shares (-328 Thousand shares)
Q3 2023
Avg closing price
$2.87
Price range
$2.40
-
$3.45
Increased shares by 138.4% (+382 Thousand shares)
Q2 2023
Avg closing price
$4.49
Price range
$3.45
-
$5.97
Sold 45.6% shares (-232 Thousand shares)
Q1 2023
Avg closing price
$11.88
Price range
$4.19
-
$16.83
Sold 49.1% shares (-490 Thousand shares)
Q4 2022
Avg closing price
$11.23
Price range
$8.74
-
$16.45
Increased shares by 50.0% (+333 Thousand shares)
Q3 2022
Avg closing price
$14.76
Price range
$10.67
-
$22.41
Increased shares by 71.2% (+277 Thousand shares)
Q2 2022
Avg closing price
$6.17
Price range
$3.94
-
$11.77
Increased shares by 481.9% (+322 Thousand shares)
Q1 2022
Avg closing price
$7.36
Price range
$5.90
-
$9.45
New holding (+66.8 Thousand shares)
Q4 2021
Avg closing price
$10.63
Price range
$8.69
-
$12.48
Sold -1.02 Million shares
Q4 2020
Avg closing price
$11.78
Price range
$7.84
-
$14.22
Increased shares by 10.7% (+98.8 Thousand shares)
Q3 2020
Avg closing price
$19.99
Price range
$9.93
-
$33.26
Increased shares by 50.0% (+309 Thousand shares)
Q2 2020
Avg closing price
$5.49
Price range
$2.90
-
$10.71
Increased shares by 255.9% (+444 Thousand shares)
Q1 2020
Avg closing price
$2.30
Price range
$1.69
-
$3.80
Increased shares by 297.5% (+130 Thousand shares)
Q4 2019
Avg closing price
$1.85
Price range
$1.53
-
$2.15
New holding (+43.6 Thousand shares)
Q3 2019
Avg closing price
$2.22
Price range
$1.95
-
$2.66
Sold -109 Thousand shares
Q2 2019
Avg closing price
$2.68
Price range
$2.19
-
$3.40
Sold 43.8% shares (-85.2 Thousand shares)
Q1 2019
Avg closing price
$2.98
Price range
$2.54
-
$4.54
Increased shares by 359.8% (+152 Thousand shares)
Q4 2018